These observations suggest that GBM is highly dependent on PRMT5 up-regulation to ensure efficient splicing [53] and that it might be a promising therapeutic target for MYC-driven tumors [141,142] (Figure 3). The gene discussed is MYC; the disease is glioblastoma.